150 related articles for article (PubMed ID: 32359108)
1. The Choice of HLA-Associated Peptide Enrichment and Purification Strategy Affects Peptide Yields and Creates a Bias in Detected Sequence Repertoire.
Nicastri A; Liao H; Muller J; Purcell AW; Ternette N
Proteomics; 2020 Jun; 20(12):e1900401. PubMed ID: 32359108
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation.
Bassani-Sternberg M; Pletscher-Frankild S; Jensen LJ; Mann M
Mol Cell Proteomics; 2015 Mar; 14(3):658-73. PubMed ID: 25576301
[TBL] [Abstract][Full Text] [Related]
3. In Immunopeptidomics We Need a Sniper Instead of a Shotgun.
Faridi P; Purcell AW; Croft NP
Proteomics; 2018 Jun; 18(12):e1700464. PubMed ID: 29377634
[TBL] [Abstract][Full Text] [Related]
4. The Choice of Search Engine Affects Sequencing Depth and HLA Class I Allele-Specific Peptide Repertoires.
Parker R; Tailor A; Peng X; Nicastri A; Zerweck J; Reimer U; Wenschuh H; Schnatbaum K; Ternette N
Mol Cell Proteomics; 2021; 20():100124. PubMed ID: 34303857
[TBL] [Abstract][Full Text] [Related]
5. High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry.
Marino F; Chong C; Michaux J; Bassani-Sternberg M
Methods Mol Biol; 2019; 1913():67-79. PubMed ID: 30666599
[TBL] [Abstract][Full Text] [Related]
6. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
[TBL] [Abstract][Full Text] [Related]
7. Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines.
Mohan SV; Datta KK; Ziegman R; Smith C; Gowda H
STAR Protoc; 2021 Mar; 2(1):100385. PubMed ID: 33778779
[TBL] [Abstract][Full Text] [Related]
8. C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells.
Hickman HD; Batson CL; Prilliman KR; Crawford DL; Jackson KL; Hildebrand WH
Hum Immunol; 2000 Dec; 61(12):1339-46. PubMed ID: 11163091
[TBL] [Abstract][Full Text] [Related]
9. Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E.
Millo E; Pietra G; Armirotti A; Vacca P; Mingari MC; Moretta L; Damonte G
J Immunol Methods; 2007 Apr; 322(1-2):128-36. PubMed ID: 17331531
[TBL] [Abstract][Full Text] [Related]
10. Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome.
Demmers LC; Heck AJR; Wu W
J Proteome Res; 2019 Apr; 18(4):1634-1643. PubMed ID: 30784271
[TBL] [Abstract][Full Text] [Related]
11. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
[TBL] [Abstract][Full Text] [Related]
12. Nonclassical HLA-G molecules are classical peptide presenters.
Diehl M; Münz C; Keilholz W; Stevanović S; Holmes N; Loke YW; Rammensee HG
Curr Biol; 1996 Mar; 6(3):305-14. PubMed ID: 8805247
[TBL] [Abstract][Full Text] [Related]
13. Toward a definition of self: proteomic evaluation of the class I peptide repertoire.
Hickman HD; Luis AD; Buchli R; Few SR; Sathiamurthy M; VanGundy RS; Giberson CF; Hildebrand WH
J Immunol; 2004 Mar; 172(5):2944-52. PubMed ID: 14978097
[TBL] [Abstract][Full Text] [Related]
14. IMBAS-MS Discovers Organ-Specific HLA Peptide Patterns in Plasma.
Wahle M; Thielert M; Zwiebel M; Skowronek P; Zeng WF; Mann M
Mol Cell Proteomics; 2024 Jan; 23(1):100689. PubMed ID: 38043703
[TBL] [Abstract][Full Text] [Related]
15. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
[TBL] [Abstract][Full Text] [Related]
16. Spliced HLA-bound peptides: a Black Swan event in immunology.
Faridi P; Dorvash M; Purcell AW
Clin Exp Immunol; 2021 May; 204(2):179-188. PubMed ID: 33644851
[TBL] [Abstract][Full Text] [Related]
17. HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern.
Wainwright SD; Biro PA; Holmes CH
J Immunol; 2000 Jan; 164(1):319-28. PubMed ID: 10605026
[TBL] [Abstract][Full Text] [Related]
18. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.
Lee N; Malacko AR; Ishitani A; Chen MC; Bajorath J; Marquardt H; Geraghty DE
Immunity; 1995 Nov; 3(5):591-600. PubMed ID: 7584149
[TBL] [Abstract][Full Text] [Related]
19. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules.
Daniel S; Brusic V; Caillat-Zucman S; Petrovsky N; Harrison L; Riganelli D; Sinigaglia F; Gallazzi F; Hammer J; van Endert PM
J Immunol; 1998 Jul; 161(2):617-24. PubMed ID: 9670935
[TBL] [Abstract][Full Text] [Related]
20. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
Braud V; Jones EY; McMichael A
Eur J Immunol; 1997 May; 27(5):1164-9. PubMed ID: 9174606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
